ASCENDIA PHARMACEUTICALS Trademark

Trademark Overview

On Friday, May 24, 2013, a trademark application was filed for ASCENDIA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ASCENDIA PHARMACEUTICALS trademark a serial number of 85942215. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Friday, July 26, 2024. This trademark is owned by Ascendia Pharmaceuticals LLC. The ASCENDIA PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services
ascendia pharmaceuticals

General Information

Serial Number85942215
Word MarkASCENDIA PHARMACEUTICALS
Filing DateFriday, May 24, 2013
Status713 - CANCELLED - SECTION 18
Status DateFriday, July 26, 2024
Registration Number4566570
Registration DateTuesday, July 15, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateFriday, July 26, 2024
Primary Code042
First Use Anywhere DateFriday, August 10, 2012
First Use In Commerce DateFriday, August 10, 2012

Trademark Owner History

Party NameASCENDIA PHARMACEUTICALS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNORTH BRUNSWICK, NJ 08902
Party NameAscendia Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Monday, September 9, 2013ASSIGNED TO EXAMINER
Wednesday, September 11, 2013NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2013NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 28, 2013NEW APPLICATION ENTERED
Wednesday, June 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 8, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 8, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Monday, March 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 25, 2014ASSIGNED TO LIE
Tuesday, March 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 24, 2017CANCELLATION INSTITUTED NO. 999999
Tuesday, July 15, 2014REGISTERED-PRINCIPAL REGISTER
Monday, July 15, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 28, 2020TEAS SECTION 8 & 15 RECEIVED
Friday, May 14, 2021NOTICE OF SUIT
Wednesday, December 15, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 9, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Monday, February 14, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, February 14, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 14, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, July 26, 2024CANCELLED SECTION 18-TOTAL
Friday, April 8, 2022CANCELLATION GRANTED NO. 999999
Saturday, July 15, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 18, 2024CT DECISION: DISMISSED
Friday, July 26, 2024CANCELLATION TERMINATED NO. 999999

Related Keywords

pharmaceuticals ascendia pharmaceutical development research services drug products